Publications by authors named "Holly M Robb"

Claim this Profile
C
Chronic integrated stress response causes dysregulated cholesterol synthesis in white matter disease.
Karin Lin, Nina Ly, Rejani B Kunjamma, Ngoc Vu, Bryan King, Holly M Robb

JCI Insight· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic TNF Inhibitors Exhibit Differential Levels of Efficacy in Accelerating Cutaneous Wound Healing.
Yonghao Cao, Bohdan P Harvey, Liang Jin, Susan Westmoreland, Jing Wang, Holly M Robb

JID Innov· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
eIF2B activator prevents neurological defects caused by a chronic integrated stress response.
Yao Liang Wong, Lauren LeBon, Ana M Basso, Kathy L Kohlhaas, Arthur L Nikkel, Holly M Robb

Elife· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nicotinic modulation of auditory evoked potential electroencephalography in a rodent neurodevelopmental model of schizophrenia.
Kathy L Kohlhaas, Holly M Robb, Victoria A Roderwald, Lynne E Rueter

Biochem Pharmacol· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disturbances in slow-wave sleep are induced by models of bilateral inflammation, neuropathic, and postoperative pain, but not osteoarthritic pain in rats.
Laura J Leys, Katharine L Chu, Jun Xu, Madhavi Pai, He S Yang, Holly M Robb

Pain· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of the novel α7 nicotinic acetylcholine receptor agonist ABT-107 on sensory gating in DBA/2 mice: pharmacodynamic characterization.
Richard J Radek, Holly M Robb, Karen E Stevens, Murali Gopalakrishnan, Robert S Bitner

J Pharmacol Exp Ther· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacological properties and procognitive effects of ABT-288, a potent and selective histamine H3 receptor antagonist.
Timothy A Esbenshade, Kaitlin E Browman, Thomas R Miller, Kathleen M Krueger, Victoria Komater-Roderwald, Holly M Robb

J Pharmacol Exp Ther· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of 4-(5-(4-chlorophenyl)-2-methyl-3-propionyl-1H-pyrrol-1-yl)benzenesulfonamide (A-867744) as a novel positive allosteric modulator of the alpha7 nicotinic acetylcholine receptor.
Ramin Faghih, Sujatha M Gopalakrishnan, Jens Halvard Gronlien, John Malysz, Clark A Briggs, Holly M Robb

J Med Chem· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical characterization of A-582941: a novel alpha7 neuronal nicotinic receptor agonist with broad spectrum cognition-enhancing properties.
Karin R Tietje, David J Anderson, R Scott Bitner, Eric A Blomme, Paul J Brackemeyer, Holly M Robb

CNS Neurosci Ther· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Broad-spectrum efficacy across cognitive domains by alpha7 nicotinic acetylcholine receptor agonism correlates with activation of ERK1/2 and CREB phosphorylation pathways.
Robert S Bitner, William H Bunnelle, David J Anderson, Clark A Briggs, Jerry Buccafusco, Holly M Robb

J Neurosci· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis